[Potential application of oligodeoxynucleotides for rheumatoid arthritis].
Tomita
Tetsuya
T
Department of Orthopaedics, Osaka University Graduate School of Medicine.
Hashimoto
Hideo
H
Kunugiza
Yasuo
Y
Yoshikawa
Hideki
H
D001172:Arthritis, Rheumatoid / Q000628:therapy*; D018797:Cell Cycle Proteins / Q000235:genetics / Q000627:therapeutic use; D004268:DNA-Binding Proteins / Q000235:genetics / Q000627:therapeutic use; D050684:E2F Transcription Factors; D018816:Genes, cdc; D006801:Humans; D016328:NF-kappa B / Q000235:genetics / Q000627:therapeutic use; D020319:Oligodeoxyribonucleotides, Antisense / Q000235:genetics / Q000627:therapeutic use*; D016337:RNA, Catalytic / Q000235:genetics / Q000627:therapeutic use; D014157:Transcription Factors / Q000235:genetics* / Q000627:therapeutic use
D018797:Cell Cycle Proteins; D004268:DNA-Binding Proteins; D050684:E2F Transcription Factors; D016328:NF-kappa B; D020319:Oligodeoxyribonucleotides, Antisense; D016337:RNA, Catalytic; D014157:Transcription Factors